Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × Vorinostat × Clear all

NCT00132067 2019-07-23

Vorinostat in Treating Patients With Recurrent or Persistent Ovarian Epithelial or Primary Peritoneal Cavity Cancer

Phase 2 Completed

Carcinoma, Ovarian Epithelial